Concurrent Investment Advisors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.6M Sell
160,097
-5,533
-3% -$899K 0.26% 80
2025
Q4
$32.3M Buy
165,630
+57,290
+53% +$13.6M 0.37% 54
2025
Q3
$30.5M Buy
108,340
+4,174
+4% +$1.06M 0.52% 36
2025
Q2
$22.8M Sell
104,166
-10,507
-9% -$1.7M 0.44% 45
2025
Q1
$16M Buy
114,673
+14,579
+15% +$2.37M 0.39% 49
2024
Q4
$16.7M Buy
100,094
+11,570
+13% +$2.06M 0.45% 45
2024
Q3
$15.1M Buy
88,524
+5,102
+6% +$739K 0.45% 46
2024
Q2
$11.8M Buy
83,422
+24,915
+43% +$3.09M 0.39% 54
2024
Q1
$7.35M Buy
58,507
+14,240
+32% +$1.63M 0.3% 78
2023
Q4
$4.67M Buy
+44,267
New +$4.83M 0.22% 102

Other funds holding ORCL

Concurrent Investment Advisors's ORCL Position: Q1 2026 in Review

Concurrent Investment Advisors reduced its Oracle (ORCL) stake by 3.3% in Q1 2026, selling an estimated $899K and leaving 160,097 shares worth $23.6M. The position accounts for 0.26% of the portfolio, ranked #80.

Concurrent Investment Advisors first reported a position in ORCL in Q4 2023 and has held it in 10 quarters since. The position peaked at $32.3M in Q4 2025. 3,473 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Concurrent Investment Advisors held 160,097 shares of Oracle worth $23.6M as of Q1 2026.
  • Concurrent Investment Advisors sold 5,533 Oracle shares in Q1 2026, an estimated $899K.
  • Oracle made up 0.26% of Concurrent Investment Advisors's portfolio in Q1 2026, its #80 holding.
  • Concurrent Investment Advisors first reported a position in Oracle in Q4 2023 and has held it in 10 quarters since.
  • Concurrent Investment Advisors's Oracle position peaked at $32.3M in Q4 2025.
  • 3,473 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.